Drugs / Sodium Demethylcantharidate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04673396 Comparator | Sep 2020 → Dec 2021 | cancer | Beijing Nuokangda Pharmaceutical Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Demethylcantharidate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04673396 ↗ |
| Route | Other | “add 250 mL of 5% glucose injection for slow dripping” NCT04673396 ↗ |